Sarepta Therapeutics, Inc. (SRPT): Price and Financial Metrics
SRPT Stock Summary
- With a price/sales ratio of 19.59, Sarepta Therapeutics Inc has a higher such ratio than 94.55% of stocks in our set.
- Over the past twelve months, SRPT has reported earnings growth of 175.18%, putting it ahead of 92.92% of US stocks in our set.
- As for revenue growth, note that SRPT's revenue has grown 42.76% over the past 12 months; that beats the revenue growth of 87.7% of US companies in our set.
- Stocks that are quantitatively similar to SRPT, based on their financial statements, market capitalization, and price volatility, are PTCT, RTRX, NEU, SPPI, and XXII.
- SRPT's SEC filings can be seen here. And to visit Sarepta Therapeutics Inc's official web site, go to www.sarepta.com.
SRPT Stock Price Chart More Charts
SRPT Price/Volume Stats
Sarepta Therapeutics, Inc. (SRPT) Company Bio
Sarepta Therapeutics is a biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment of rare, infectious and other diseases. The company was founded in 1980 and is based in Cambridge, Massachusetts.